Lilly launches Mounjaro in India for treatment of obesity and type 2 diabetes
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
PROVIGIL and NUVIGIL are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy
Express Scripts to add Zepbound to National Preferred Formulary
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Study to evaluate effectiveness of hypoglossal nerve stimulation
This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports
Subscribe To Our Newsletter & Stay Updated